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Abstract 
Numerous studies have examined how alexithymia (difficulty identifying and describing one’s 
emotions and a preference for externally-oriented thinking) relates to chronic pain and associated 
disability. We conducted a systematic review and meta-analysis to summarize individual studies 
that either assessed alexithymia in individuals with chronic pain versus controls or related 
alexithymia to pain intensity, physical interference, depression and anxiety.  We searched 
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MEDLINE, Embase and PsycINFO from inception through June 2017; 77 studies met criteria 
(valid assessment of alexithymia in adults or children with any chronic pain condition) and were 
included in analyses (n = 8019 individuals with chronic pain). Primary analyses indicated that 
chronic pain samples had significantly higher mean alexithymia scores compared to non-clinical 
(d = 0.81) and clinical non-pain (d = 0.55) controls. In chronic pain samples, alexithymia was 
significantly positively associated with pain intensity (d=0.20), physical interference (d=0.17), 
depression (d = 0.46), and anxiety (d = 0.43). Secondary meta-analyses of 14 studies that 
conducted partial correlations that controlled for negative affect-related measures revealed that 
alexithymia was no longer significantly related to pain intensity or interference. Meta-analysis 
findings demonstrated that alexithymia is elevated in individuals with chronic pain and related to 
greater pain intensity and physical interference, although the latter relationships may be 
accounted for by negative affect. Critical future work is needed that examines alexithymia 
assessed using non-self-report measures, develops a person-centered perspective on this 
construct, and identifies how alexithymia is relevant to the assessment and treatment of 
individuals with chronic pain.  
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Introduction 
Chronic pain is common, occurring in around 11% – 31% of adults [52; 89] and children 
[48; 57]. Chronic pain impacts physical, social, and emotional functioning [14; 95] and can be 
severely disabling [48; 89]. Chronic pain is also associated with heightened symptoms of 
depression and anxiety [2; 91; 104]. Given the high costs and societal burden of chronic pain 
[32; 39] identifying biopsychosocial treatment targets to improve functioning in this population 
is critical. 
 Individual differences in emotional awareness may relate to the experience of chronic 
pain, and various constructs within this domain have been studied and debated. One specific 
concept, labeled with the term alexithymia, has received considerable theoretical and empirical 
attention over the past several decades [120]. Alexithymia refers to the inability to label and 
describe one’s emotions and a preference for externally-oriented thinking [112]. Alexithymia has 
been assessed primarily with self-report measures, the most common of which is the Toronto 
Alexithymia Scale-20 (TAS-20; [6]). Alexithymia has been found to be elevated in adults and 
youth with chronic pain compared to healthy samples [23; 33], and may be associated with 
greater pain intensity and disability [3; 74]. In addition, alexithymia is associated with greater 
depressive and anxiety symptoms in various populations [65; 66] including individuals with 
chronic pain [25]. This may be because alexithymia relates to reduced ability to successfully 
regulate, or reduce, negative emotion [117]. Although a number of factors – such as self-
efficacy, stressor intensity, contextual cues, and cultural norms – influence an individual’s choice 
of emotion regulation strategy, increased awareness of one’s emotional states is thought to be 
key to taking active steps towards adaptive emotion regulation [41; 56]. In his extended process 
theory of emotion regulation, Gross [41] explains that emotion identification enables an 
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individual to take adaptive steps to regulate their emotions, and is thus an essential first step in 
the emotion regulation process. Lieberman and colleagues [67; 68] show that the simple act of 
applying a verbal label to one’s emotional state results in reductions in negative affect both 
subjectively and neurologically, further demonstrating the emotion regulating properties of 
emotional awareness. 
 Although the majority of research examining the relationship between alexithymia and 
chronic pain has relied on cross-sectional methods, some prospective studies show alexithymia 
may constitute a risk factor for pain outcomes [10; 102]. Recent research highlights the 
malleability of alexithymia with psychological interventions [11; 15; 81], which increases the 
relevance of alexithymia to chronic pain clinical practice. For example, in a recent single-arm 
trial, adults with chronic musculoskeletal pain undergoing group intervention targeting emotional 
awareness and expression demonstrated improvements in alexithymia, which were associated 
with reductions in psychological distress as well as improvements in pain intensity and 
interference [13]. A better understanding of the relationship between alexithymia and chronic 
pain has potential to clarify aspects of emotion awareness that relate to chronic pain and lead to 
more specific psychological prevention or intervention programs to improve emotional 
functioning in individuals with chronic pain.  
A great deal of research has examined alexithymia in individuals with chronic pain; 
however, no systematic reviews or meta-analyses of this literature have been conducted to 
summarize individual studies and provide estimates of the magnitude of the relationships 
between alexithymia and relevant pain variables. We conducted a systematic review of 
alexithymia in people with chronic pain and its relation to pain intensity, physical interference, 
anxiety, and depression. Specifically, we had three primary aims: (1) to determine levels of 
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alexithymia in adults and youth with chronic pain; (2) to estimate the magnitude of the difference 
in alexithymia levels between samples with chronic pain and various comparison samples; and 
(3) to estimate the associations between alexithymia and pain intensity, physical function, and 
symptoms of depression and anxiety in people with chronic pain. There is ongoing debate in this 
field as to whether observed associations between measures of alexithymia, pain intensity and 
functional impairment are confounded by depression or psychological distress [45; 77]. Thus, a 
secondary aim was to identify and summarize studies that covaried measures of negative affect 
when testing the relationship between alexithymia and pain intensity and interference. In 
conducting the present systematic review and meta-analysis, we hope to make the available 
evidence more accessible, to facilitate a critical examination of the application of this construct, 
and to generate broad conclusions that help pave the path for next steps in the area of emotions 
and pain. 
Methods 
The systematic review and meta-analysis protocol for the current study was registered on 
September 25th, 2017 and can be found through PROSPERO (ID: CRD42017077551).  
Search Methods 
 We conducted systematic searches in Medline, PsycINFO, and EMBASE, from the 
inception of each database through June 2017. We included general search terms of “pain,” 
“alexithymia,” and related search terms to capture all studies conducted in this area.  See 
Appendix for the specific search criteria. Two authors (RA and EF) independently sorted through 
abstracts to determine possible relevance (available as supplemental digital content at 
http://links.lww.com/PAIN/A734). The two resulting abstract lists were then reviewed together, 
and inconsistencies were resolved. Where disagreements emerged, a third author (TP) was 
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consulted until 100% agreement was achieved. Next, articles identified as possibly relevant were 
reviewed in full to determine their eligibility against inclusion/exclusion criteria. Once a final set 
of studies was generated from our search, we reviewed their reference lists to ensure other 
relevant articles had not been overlooked. Studies identified in this manner were then reviewed 
and assessed for eligibility. In addition, as described below, we contacted authors of articles that 
were missing key data or analyses to request those data. 
Inclusion Criteria 
Inclusion criteria for individual studies were the following: (1) included youth (<18 
years) or adults (≥18 years) with chronic pain conditions including, but not limited to, headache, 
abdominal pain, musculoskeletal pain, and autoimmune disease-related pain; (2) assessed 
alexithymia using an established, psychometrically-sound measure; and (3) published in English 
in a peer-reviewed journal.  
Exclusion Criteria 
We excluded studies that: (1) included chronic pain participants with primary psychiatric 
diagnoses (e.g., substance abuse); (2) combined individuals with acute and chronic pain without 
reporting data separately for these groups; (3) screened and recruited based on “high” or “low” 
alexithymia; and (4) had less than 20 participants.  
Data extraction 
Data were extracted by RA and RV. We extracted only the baseline data from 
longitudinal studies. When data from the same study were published in different articles, we 
extracted data from the earliest published article that met our inclusion criteria, unless a 
subsequently published article reported a larger sample size. Some studies provided data on 
distinct pain samples (e.g., people with fibromyalgia vs headache). Some studies also provided 
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data on non-clinical comparison samples and/or non-pain clinical samples (e.g., diabetes).  These 
data were extracted separately.  
Study Characteristics. We extracted study characteristics including sample size, chronic 
pain characteristics (condition, location, duration), and demographic information (age, sex, 
country of study) from included studies.  When studies included a comparison sample, we 
extracted the sample size and type of comparison.  
Alexithymia. Measures of alexithymia typically yield a continuous alexithymia score and 
a clinical cutoff score. The most commonly-used measure, the Toronto Alexithymia Scale-20 
(TAS-20; [6]), which was adapted from the original 26-item TAS [5]. The TAS-20 yields a 
continuous score ranging from 20-100, with higher scores indicating greater alexithymia and a 
clinical cutoff score of ≥ 61, indicating elevated alexithymia [108]. The TAS-20 has three 
subscales: difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and 
externally-oriented thinking (EOT). The Alexithymia Questionnaire for Children (AQC) [105] is 
parallel to the TAS-20 but is linguistically adapted for children. We extracted mean alexithymia 
total and subscale scores, and percentage of people above clinical cut-off scores in both chronic 
pain and comparison samples. We also recorded information on how alexithymia was assessed 
(i.e., assessment tool, scoring parameters).  
Correlation Analysis. We extracted correlation coefficients describing the relationship 
between alexithymia and pain intensity, physical interference, anxiety, and depression. Some 
studies have examined partial correlations between alexithymia and pain intensity and physical 
interference while controlling for an index of depression or psychological distress. In the present 
review, we identified studies that conducted such partial correlations and extracted the resulting 
correlation coefficients for use in a secondary meta-analysis of partial correlations. A number of 
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studies reported correlations selectively, based on significance. Where we were unable to achieve 
representative analyses, we applied a rule established a priori to exclude selectively reported 
findings to avoid biasing results towards statistically significant findings. 
Study Quality. For the purpose of better characterizing studies included in the meta-
analysis, we extracted information related to study quality. We adapted the National Institutes of 
Health Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [90], 
excluding items that were irrelevant or inconsistent with our study inclusion/exclusion criteria. 
Of the remaining items, some were adapted or reworded to more directly align with our criteria. 
Given the numerous international studies in this field, we evaluated whether authors included an 
alexithymia measure that had been validated in their country’s language. We assigned studies 
one point per each criterion met, which were summed for a total quality score of 0 – 8 (0 
indicating lowest quality and 8 highest quality).  
Missing Data. Of studies that met our inclusion criteria, many were missing some or all 
data points relevant to our meta-analyses. In many cases, it was clear from the authors’ methods 
section that relevant variables had been measured. Specifically, we requested: (1) means and SDs 
of alexithymia total and subscale scores; (2) correlations between alexithymia and key variables 
(pain intensity, physical interference, depression, and anxiety); and (3) partial correlations of 
alexithymia with pain intensity and physical interference, controlling for negative affect (e.g., 
explicit measures of negative, depression, or anxiety). We provided one follow-up email for 
those authors who did not initially respond.  
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Data Analysis 
For Aim 1, we summarized alexithymia (total and subscales) scores and percentage of 
people exceeding clinical cut-off scores separately for adults and youth with chronic pain. All 
pooled means were calculated using the formula indicated in Higgins and Green [44] (p. 177).  
For Aim 2, we meta-analyzed the effect sizes of group differences in alexithymia scores 
between chronic pain and comparison groups with random effects models, using Review 
Manager 5.1. We calculated standardized mean differences and 95% confidence intervals (CI). 
Some studies compared two chronic pain samples to a single nonclinical comparison sample. In 
such cases, we extracted each of these comparisons separately and halved the n of the nonclinical 
sample to prevent inflating the weight of the individual study. For total alexithymia scores, we 
included in our analyses any alexithymia measure and scoring convention. However, for 
alexithymia subscale analyses, we examined only the TAS-20, given that this was the most 
commonly used measure, and other measures have different factor structures.  
For Aim 3, we meta-analyzed correlations of alexithymia with pain intensity, physical 
interference, depression, and anxiety using random effects models. Finally, for our secondary 
analysis, we meta-analyzed partial correlations that examined the relationship between 
alexithymia and pain intensity and physical interference when controlling for measures of 
negative affect, using random effects models. Meta-analyses of correlation coefficients were 
conducted in STATA using the DerSinonian-Laird random effects method. We examined effect 
size and 95% CIs. When there were more than eight studies in a meta-analysis, trim and fill 
analyses were used to detect publication bias using Duval and Tweedie’s [27] method and 
Rosenthal’s failsafe N (1979). Trim and fill analyses evaluate the overall effect and variance of 
each study included in a meta-analysis, identifies possible missing studies that may have resulted 
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from publication bias (e.g., selective publication of statistically significant results), and imputes 
values for these missing studies [27]. We subsequently re-ran meta-analyses to ensure significant 
findings were not the result of publication bias.  
For all meta-analyses, we considered between-study heterogeneity (I2), and interpreted 
findings using Cochrane standards as a guide (Higgins & Green, 2011 [44]). Specifically, we 
adopted the following cut-offs for describing heterogeneity: (0-29% low heterogeneity; 30-49% 
moderate heterogeneity; 50-74% substantial heterogeneity; 75-100% considerable 
heterogeneity). To explore whether variability in study quality influenced study findings, we 
conducted correlations between effect size estimates and quality ratings for analyses of group 
differences in alexithymia, and for analyses of correlations of alexithymia with pain intensity, 
physical interference, depression, and anxiety. 
 
 
Results 
Study Selection 
Our systematic search resulted in 1,240 abstracts. After screening these abstracts, we identified 
157 full texts to review for eligibility. Through review, we excluded 80 studies (see Figure 1). 
This resulted in 77 full studies for analysis. Among these 77 studies, ten reported data from 
distinct chronic pain samples (e.g., a study reported data from two distinct samples of individuals 
with an autoimmune disease and headache). We preserved data from these distinct samples, and 
therefore included a total of 87 chronic pain samples in our review. We use the terminology 
“study” to identify overarching studies, or articles, and the terminology “sample” to identify a 
distinct group of individuals with chronic pain.  
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Missing Data 
We contacted 71 authors to request additional data and analyses. Additional data were obtained 
for 22 studies. Authors of an additional 17 studies responded but could not complete the request 
because they lacked access to the original data (n=12) or their schedules were too busy (n=5).  
Study Characteristics 
From the 77 studies, there were data from 82 adult and 5 youth chronic pain samples (Table 1). 
Of note, one additional study examined a mixed sample of adolescents and young adults (aged 
16-20 years) with inflammatory bowel disease or irritable bowel syndrome [46]. 
Developmentally, alexithymia scores in individuals within this age range are more similar to 
adults [97] and therefore we categorized this study as an adult sample. 
From 82 adult samples (across 77 studies), data were available on alexithymia mean 
scores or clinical cut-off scores from 74 (90%), comparison of alexithymia scores of a chronic 
pain sample to a comparison sample from 34 (41%), zero-order correlations between alexithymia 
and pain intensity, physical interference, depression and/or anxiety from 40 (49%), and partial 
correlations from 14 (17%). From 5 youth samples (across 5 studies), we obtained alexithymia 
mean scores or clinical cut-off scores from four; correlations between alexithymia and key 
variables of interest from two; and group differences between a chronic pain and comparison 
sample from one. There were not enough extractable data in studies of youth to conduct meta-
analyses. All included studies used some variation of the Toronto Alexithymia Scale, including 
the TAS-26 (k=14), TAS-20 (k=72), and Alexithymia Questionnaire for Children (AQC; k=1). 
In this case, the AQC was scored using the same scale as the TAS-20 (i.e., 20-100). Other 
psychometrically-sound self-report measures (e.g., Bermond-Vorst Alexithymia Questionnaire 
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[130]) or clinician-administered measures (e.g., Toronto Structured Interview for Alexithymia 
[7]) of alexithymia were not utilized in this body of literature. 
Pooled means and prevalence of alexithymia in individuals with chronic pain 
Among the 82 samples of adults with chronic pain, TAS-20 total scores were available for 61, 
and TAS-26 total scores available for nine. The pooled means of TAS-26 total and TAS-20 total 
and subscale scores are presented in Table 2. In addition to total scores, the percentage of 
individuals with a total alexithymia score beyond the clinical cut-off score for TAS-20 was 
available for 39 samples (n=4092). Of these, 28% of adults with chronic pain exceeded this 
threshold. The percentage of individuals with a total alexithymia score beyond the clinical cut-
off scores for TAS-20 was available for five samples (n=460); of these, 36% of adults exceeded 
this threshold. 
Two studies including youth reported mean alexithymia using a standard scoring 
convention: Gatta et al. (2011) measured alexithymia using the AQC in a sample of 32 youth 
with tension-type headache and reported a mean total score of 58.13 (SD = 10.64). Cerutti et al. 
(2016) assessed alexithymia with the TAS-20 in 53 youth with migraines and reported a mean 
total score of 56.3 (SD = 12.14); 31% of the youth exceeded clinical cutoffs for alexithymia. 
These data should be interpreted with caution, however, as the validity of applying adult-derived 
clinical cutoff scores to characterize alexithymia in youth has been questioned [97].  
Group differences in alexithymia in pain versus comparison groups.  
We examined group differences in alexithymia total scores in adults with chronic pain (n=1706) 
compared to non-clinical comparison samples (n=1370; k=27). We also examined four studies 
that compared alexithymia total scores in adults with chronic pain (n=170) compared to non-pain 
clinical comparison samples (n=207). One study in the latter analysis was an outlier, reporting an 
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unexpectedly large effect size difference in alexithymia and was excluded from analyses [103]. 
A significant and large group difference in total alexithymia between adults with chronic pain 
and non-clinical comparison samples remained (d = 0.81, 95% CI 0.62, 1.00), although with 
substantial heterogeneity (I2 = 83%). Among studies that compared alexithymia total scores in 
adults with chronic pain to non-pain clinical comparison samples (k=4), there was a statistically 
significant medium sized effect (d = 0.55, 95% CI 0.34, 0.77) with no observed heterogeneity (I2 
= 0%). A forest plot depicting group differences in alexithymia total scores is presented in Figure 
2.  
We also examined group differences in alexithymia subscale scores (see Table 3). Adults 
with chronic pain had greater difficulty identifying feelings scores compared to non-clinical 
samples, and this was statistically significant with a large effect size. Adults with chronic pain 
had greater difficulty describing feelings compared to non-clinical samples with a medium effect 
size. Findings were similar for group differences between adults with chronic pain and non-pain 
clinical comparison samples. There was no statistically significant group difference in externally-
oriented thinking between adults with chronic pain and non-clinical samples. There were too few 
studies to examine group differences in externally-oriented thinking between adults with chronic 
and non-pain clinical samples, as well as group differences in alexithymia total and subscale 
scores in youth.  
Relationships of alexithymia with pain intensity, physical interference, depression, and 
anxiety within pain samples 
As shown in Table 4, we found significant, small magnitude, positive correlations between 
alexithymia and pain intensity and pain interference, and significant, medium-size magnitude, 
positive relationships between alexithymia and depression and anxiety. Across all analyses, 
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difficulty identifying feelings was the most strongly associated alexithymia subscale with these 
measures, followed by difficulty describing feelings. Small relationships were observed between 
externally-oriented thinking and all variables except pain interference. Trim and fill analyses 
identified missing studies in just one analysis (relationship between externally-oriented thinking 
and depression). When missing studies were subsequently filled, the pattern of significance 
remained the same. 
  Only two studies examined these correlations in youth; thus meta-analyses for youth 
could not be conducted. One study showed a significant positive relationship between 
alexithymia and anxiety, and a nonsignificant relationship between alexithymia and depression 
[110] in a small sample (n=21) of youth with mixed headache and abdominal pain. The other 
study showed significant correlations between alexithymia and anxiety and depression in a 
sample of youth with migraine [18]. 
Meta-analysis of partial correlations controlling for psychological distress. 
Partial correlations between alexithymia and pain measures (intensity and interference) were 
published in only three studies, and we obtained unpublished data from authors of 11 additional 
studies (thus, k = 14). We meta-analyzed partial correlations between alexithymia (total and 
subscale scores), pain intensity and pain interference while controlling for negative affect.  As 
shown in Table 5, there were no significant partial correlations of alexithymia total or subscale 
scores with pain intensity and pain interference. 
Quality Assessment 
Overall quality ratings are depicted in Figure 3, offering a relative assessment of the overall 
quality of included studies. For studies of adults, quality ratings ranged from 2 to 8 (mean = 5.13, 
SD = 1.21; median = 5). For youth studies, quality ranged from 3 through 6 (mean = 4.60, 
CC
EP
TE
D
Copyright  8 8 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.            2019
Page 15 
 
median = 5). Study quality was not significantly correlated with effect size for group differences 
in alexithymia (r = .13, p = .429) or correlations of alexithymia with pain intensity (r = -0.21, p = 
.282), physical interference (r = .20, p = .403), depression (r = .29, p = .138) or anxiety (r = 0.10, 
p = .650). 
Discussion 
This is the first systematic review and meta-analysis of alexithymia in individuals with 
chronic pain. We identified a large number of articles (k = 77), reflecting substantial interest in 
the assessment of alexithymia, primarily in adults, with a range of pain conditions. Overall, our 
findings demonstrated that alexithymia was higher in individuals with chronic pain compared to 
both non-clinical samples (large effect) as well as clinical samples without pain (medium effect). 
The latter finding suggests that the elevated alexithymia is not solely a bias associated with 
health care seeking or having a chronic illness. We found that 26% of adults with chronic pain 
met the threshold of a clinical cutoff score for alexithymia—an estimate that is higher than the 
13% reported in the general population [108]. In addition to elevated alexithymia in people with 
chronic pain, our meta-analyses indicated that, among adults with chronic pain, alexithymia was 
associated with greater pain intensity and physical interference, with correlations that were small 
in magnitude. Alexithymia was also positively associated with depression and anxiety, with 
correlations that were medium in magnitude.  
 Among adults with chronic pain, greater alexithymia was associated with greater pain 
intensity and physical interference, with small magnitude effect sizes. These findings are 
consistent with laboratory-based studies demonstrating altered pain processing in relation to 
heightened alexithymia in healthy adults [47; 54; 92]. As expected, alexithymia was associated 
with greater depression and anxiety with large effect sizes. Emotional awareness is important for 
AC
CE
PT
ED
Copyright  8 8 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.            2019
Page 16 
 
effective emotion regulation [40; 56], and alexithymia is associated with reliance on ineffective 
approaches to emotion regulation including suppression and avoidance [96; 117]. The experience 
of chronic pain confers additional stress in many life domains (e.g., social, emotional, physical) 
[121]; in the face of these stressors, alexithymia may be associated with greater difficulty 
regulating emotions, contributing to poor mental health outcomes [71]. 
Specific subscales of alexithymia measures showed differential effects; in particular 
effects were larger for difficulty identifying feelings and difficulty describing feelings, but lower 
or nonsignificant for externally-oriented thinking. Contributing to this pattern may be the weak 
psychometric properties of the externally-oriented thinking subscale of the TAS-20 [60], 
particularly in non-Western cultures [21]. It is also possible that chronic pain is more tightly 
linked to the constructs of difficulty identifying and describing feelings. With the inability to 
identify or describe one’s emotions, it is possible that awareness of or attention to interoceptive 
cues is associated with misinterpreting emotional cues as harmful or as signs of illness [72; 119]. 
Our review highlights the important need for future research on the conceptualization and 
assessment of emotional awareness as it applies to chronic pain. 
We meta-analyzed partial correlations from 14 studies that examined relationships of 
alexithymia to pain intensity and pain interference while controlling for psychological distress. 
These analyses revealed that alexithymia was no longer uniquely related to pain variables. There 
are several possible interpretations of these results. First, some scholars have questioned the 
validity of self-reported alexithymia, especially given its convergence with measures of negative 
affect [64; 69], which could spuriously inflate alexithymia’s correlations with self-reported 
measures of pain and other symptoms. Relatedly, individuals with depressive symptoms are 
more likely to evaluate themselves and their abilities negatively on a self-report survey [64; 69]. 
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Another intriguing possibility is that distress or negative affect may mediate the links between 
alexithymia and pain. Unfortunately, cross-sectional analyses such as those in the current review 
cannot differentiate these two possibilities. We also note that potential confounding by negative 
affect is by no means limited to studies of alexithymia; such bias complicates the assessment and 
interpretation of many or most self-reported psychological constructs that are related to pain 
[116; 131]. It should also be noted that only three of the 14 sets of partial correlations that we 
meta-analyzed had been peer-reviewed and published; the other 11 were provided to us directly 
by the authors at our request. Given these considerations, we suggest caution in making 
conclusions about the role of negative affect in the relationship between alexithymia and pain 
based on the current findings. Of note, the fact that partial correlation analyses were available but 
rarely published raises the issue of a publication bias in scientific literature towards positive 
findings [106]. Moving forward, we recommend that investigators examine and report the role of 
negative affect in the relationship between alexithymia or other psychological constructs and 
chronic pain, and to test alternative models (e.g., moderation, mediation) to better parse these 
relationships.  
 Results from the present systematic review and meta-analysis reveal many significant 
gaps in this large body of literature. For example, only 5 studies examined alexithymia in youth 
with chronic pain, and it is unclear whether this construct can be adequately measured in youth. 
These studies typically applied adult-derived alexithymia cutoff scores, not considered valid in 
youth populations [138]. Data were insufficient to examine group differences and correlations in 
youth with chronic pain. Future studies are needed to clarify the role of emotional awareness in 
youth with pain, using age-appropriate assessment (cf. [138]), to determine how it relates to pain 
intensity, physical interference, depression and anxiety. Adolescence is a critical window for the 
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development of emotional insight and emotion regulation (Somerville, 2016). Clarifying the role 
of emotional awareness in youth with pain may have developmental implications and unique 
treatment considerations.   
Another gap in the broad alexithymia and chronic pain literature is the preponderance of 
cross-sectional study designs. Very few studies in this field have examined temporal patterns or 
longitudinal relationships between alexithymia and chronic pain. Alexithymia may be a risk 
factor for subsequent pain where reduced ability to label and describe emotions leads to 
misperceptions of the physiological correlates of emotion as signs of illness [63; 73; 118]. On the 
other hand, chronic pain may contribute to affective deficits observed in alexithymia. 
Constructivist theories of emotion argue that the subjective experience of emotion results in part 
from awareness of bodily cues [9]. A recent systematic review concluded that individuals with 
chronic pain have reduced accuracy in detecting interoceptive cues compared to comparison 
samples [22]. The presence of pain, a potentially threatening biological cue, may distract from 
awareness of relevant interoceptive cues, particularly those subtle cues involved in daily 
experiences and interactions with others. This is an empirical question for future research.  
Addressing these gaps in the literature has potential implications for clinical intervention. 
It is possible that individuals with both chronic pain and elevated alexithymia may benefit from 
interventions that directly target processes related to emotional awareness, such as emotional 
awareness and expression training [75]. On the other hand, more general psychological 
interventions may function to reduce depression and anxiety, and in turn result in reduced 
alexithymia. Future research is needed to investigate ontological distinctions between 
alexithymia and negative affect, and if and how they relate temporally.  
AC
CE
PT
ED
Copyright  8 8 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.            2019
Page 19 
 
Current findings should be considered in light of additional limitations. There is 
substantial debate about the alexithymia construct more broadly. Alexithymia generally, and the 
TAS-20 specifically, has been criticized for relying on Western norms, which value individual 
emotional experience and verbal expression of emotion [58]. Diverging from this norm may 
indicate psychopathology in Western culture, but not necessarily in others. Nonetheless, a 
strength of the current meta-analysis is representation from many different geographic regions 
and cultures, and the TAS-20 has been validated in a number of Eastern cultures [87; 137]. 
Future studies should examine whether ethnicity or culture moderate the relationship between 
alexithymia and chronic pain. Another limitation of the TAS-20, particularly the difficulty 
identifying feelings subscale, is that it contains items pertaining to physiological sensations (e.g., 
“I have physical sensations that even doctors don’t understand;” “I am often puzzled by 
sensations in my body.”). Such items likely reflect the experience of chronic pain, artificially 
inflating correlations between the TAS-20 and pain-related measures. A number of interview or 
observer-based measures of alexithymia have been developed, though unfortunately we did not 
identify studies that made use of these assessment tools in the current meta-analysis. 
Meta-analyses in the current study were generally characterized by substantial 
heterogeneity and thus should be interpreted with caution. There may be relevant demographic or 
clinical differences that contribute to such heterogeneity. For example, the relationship of 
alexithymia to pain severity and interference may vary by sex or ethnicity [21; 93] as well as be a 
function of pain characteristics, such as duration of pain or specific pain condition. The 
examination of demographic and clinical moderators was beyond the scope of the present meta-
analysis and represent potential future avenues of research. 
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We examined study quality using general criteria and assigned a relative quality value to 
each included study. The overall mean and median quality score of included studies were 
relatively high; however, a large subset of studies was characterized by low study quality. Future 
studies with rigorous methodology and reporting are needed to increase confidence in this body 
of work. Relative areas of weakness include failing to provide sample size justification and to 
report participation rates. In addition, very few studies tested the unique validity of alexithymia 
measures by controlling for various potential confounds: future studies should consider 
accounting for demographic (e.g., education, age) and clinical factors (e.g., psychological 
distress) that relate differentially to alexithymia scores. 
In conclusion, this systematic review helps summarize a substantial literature examining 
alexithymia in chronic pain, finding that alexithymia is elevated in youth and adults with chronic 
pain conditions. In adults, alexithymia is associated with greater pain intensity, physical 
interference, depression and anxiety. Alexithymia may be relevant to the presence and severity 
of chronic pain and associated mental health symptoms. Future empirical research is needed to 
better illuminate these relationships and clarify the potentially confounding role of negative 
affect. In particular, utilizing prospective designs and non-self-repot alexithymia assessment 
tools would add greater clarity to this construct and inform development of targeted 
interventions. 
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Figure legends 
Figure 1. PRISMA flow chart diagramming studies included in meta-analyses. 
Figure 2. Summary of quality ratings across all samples (87) included in manuscript. 
Figure 3. Forest plot depicting group differences in alexithymia score between adults with 
chronic pain and non-clinical and clinical comparison samples. 
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   Study Author and Year Pain condition 
Study 
design 
Country of 
study 
pain 
group 
(N) 
Age  
(Mean and 
SD) 
Sex  
(% 
female) 
Alexithymia 
Measure  
Quality 
assessment 
(0-8) 
Adult Studies: 
        
 
Ak (2004) [1]  
Mixed chronic 
pain 
G,M Turkey 30 40.6 (11.4) 83% TAS-20 5 
 
Atagun (2012) [3] Fibromyalgia C,M Turkey 57 40.9 (6.9) 100% TAS-20 5 
 
Baeza-Velasco (2012)  
[4]* 
Mixed chronic 
pain 
C,G,M France 39 52.2 (8.9) 100% TAS-20 3 
 
Balaban (2012) [8]  Headache M Turkey 31 20.9 (1.7) 81% TAS-20 5 
 
Burger (2012) [12]*  MSK C,M USA 72 49.3 (15.6) 79% TAS-20 8 
 
Castelli (2012) [17]  TMD C,M Italy 45 38.9 (11.6) 100% TAS-20 4 
 
Castelli (2012) [16] Fibromyalgia G,M Italy 55 52.8 (10.5) 100% TAS-20 4 
 
Cerutti (2016) [18] a* Headache M Italy 53 41.8 (3.9) 53% TAS-20 4 
 
Chang (2017) [19] a Chronic pain G,M Taiwan 121 54.0 (15.6) 9% TAS-20 6 
 
Chang (2017) [19]  a Fibromyalgia G,M Taiwan 58 57.5 (15.8) 71% TAS-20 6 
 
Cologno (2005) [20] Headache M Italy 35 38.0 (9.3) 80% TAS-20 3 
 
Di Tella (2017) [24]*  Fibromyalgia C,M Italy 159 52.5 (10.2) 100% TAS-20 6 
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 Duruk (2015) [26]* Fibromyalgia C,G,M Turkey 35 41 (9.7) 100% TAS-20 6 
 
Esin (2017) [28] Headache M Russia 137 40.8 (6.3) 61% TAS-26 3 
 
Evren (2006) [29] Fibromyalgia C,M Turkey 51 37.2 (9.3) 100% TAS-20 6 
 
Fernandez (1989) [30]   Autoimmune G,M India 40 36.1 (11.3) 65% TAS-26 3 
 
Galli (2017) [31]* Headache G,M Italy 80 44.7 (8.6) 74% TAS-20 5 
 
Ghiggia (2017) [35]*   Fibromyalgia C,G,M Italy 181 51.7 (10.2) 100% TAS-20 5 
 
Glaros (2005) [36]  TMD C,G,M USA 49 39.9 (12) NR TAS-20 5 
 
Gregory (2000) [37] Chronic pain G,M USA 140 44.7 (11.2) 75% TAS-20 5 
 
Gregory (2005) [38] a Chronic pain G,M USA 46 NR NR TAS-20 6 
 
Gregory (2005) [38] a MSK G,M USA 49 NR NR TAS-20 7 
 Gulec (2008)* [42] Fibromyalgia C,M Turkey 75 43.6 (10.6) 100% TAS-20 7 
 
Haas (2013) [43]  TMD G Germany 20 40.6 (14.7) 90% TAS-26 7 
 
Hosoi (2010) [45]  Autoimmune C USA 129 52 (12.4) 56% TAS-20 6 
 
Huang (2016) [46] 
Mixed chronic 
pain 
G,M USA 20 17 (NR) 55% TAS-20 5 
 
Huber (2009) [47]* Fibromyalgia C,M Italy 68 43.4 (11.1) 100% TAS-20 5 
 
Jasinski (2016) [49]  MSK M USA 95 46.9 (9.7) 52% TAS-20 4 
 
Jerjes (2007) [50] Headache G,M UK 51 40 (13) 67% TAS-20 5 
 
Jerlang (1997) [51]  BMS M Denmark 20 67 (NR) 100% TAS-26 4 
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 Johannsen (2017) [53]*  Cancer C,M Denmark 129 56.8 (9.1) 100% TAS-20 4 
 
Karahan (2016) [55]  Autoimmune G,M Turkey 148 52.6 (12.0) 78% TAS-20 5 
 
Kojima (2014) [59]* Autoimmune C,M Japan 213 60 (12) 82% TAS-20 7 
 
Kosturek (1998) [61]  MSK M USA 50 43.6 (10.9) 46% TAS-20 6 
 
Kugu (2009) [62]  Fibromyalgia G,M Turkey 54 48.1 (8.1) 100% TAS-20 4 
 
Lumley (1997) [70] Chronic pain C,G USA 30 40.4 (NR) 70% TAS-26 5 
 Lumley (2002) [76]*   Myofascial C,M USA 80 48.7 (11.8) 75% TAS-20 6 
 
Lumley (2005) [74] a Autoimmune C,M USA 155 55 (NR) 88% TAS-20 5 
 
Lumley (2005) [74] a Headache C,M USA 160 31.8 (NR) 84% TAS-20 5 
 
Makino (2013) [77]  
Mixed chronic 
pain 
C,M Japan 128 52.3 (16.3) 74% TAS-20 7 
 
Margalit (2014) [78]  a CRPS C,M Israel 30 38.3 (14.3) 40% TAS-20 5 
 Margalit (2014) [78] a MSK C,M Israel 30 38.2 (12.5) 40% TAS-20 5 
 
Marino (2015) [79]  BMS C,G,M Italy 58 65.6 (10.5) 79% TAS-20 4 
 
Martínez (2015) [80]*  Fibromyalgia C Spain 100 48.4 (7.5) 100% TAS-20 4 
 
Melin (2010) [81]* Chronic pain C,M Sweden 59 46 (NR) 88% TAS-20 4 
 
Melis (2014) [82]*  Pelvic pain C,M Italy 41 31.5 (6.4) 100% TAS-20 5 
 
Millard (1992) [83] 
Mixed chronic 
pain 
C,M USA 194 42.8 (11.2) 64% TAS-26 5 
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 Mingarelli (2013) [84]  TMD C,M Italy 132 39.2 (13.6) 85% TAS-20 7 
 
Miyaoka (1996) [85]  BMS G Japan 50 55.8 (8.7) 100% TAS-26 2 
 
Montoro (2016) [86]*  Fibromyalgia C,G,M Spain 55 51.9 (8.8) 100% TAS-20 6 
 
Muftuoglu (2004) [88]  Headache G Turkey 50 32.1 (NR) 64% TAS-26 4 
 
Ozturk (2015) [94]  Mastalgia M Turkey 88 29.6 (8.2) 100% TAS-20 6 
 
Pecukonis (2009) [98] MSK G USA 59 33.3 (11.9) 100% TAS-26 6 
 
Peñacoba (2013) [99]  Fibromyalgia G Spain 120 50.9 (9.8) 100% TAS-20 5 
 
Pepe (2014) [100]* MSK C,M Italy 40 44.8 (9.7) 30% TAS-20 6 
 
Porcelli (2014) [101]* IBS C,M Italy 177 34.5 (11.7) 71% TAS-20 5 
 
Portincasa (2003) [103]  IBS G,M Italy 100 48 (2) 27% TAS-20 4 
 
Saariaho (2016) [107]  Chronic pain C,M Finland 83 49.5 (7.19) 41% TAS-20 5 
 
Sayar (2004) [109] a Fibromyalgia C,M Turkey 50 40.5 (8.8) 100% TAS-20 4 
 
Sayar (2004) [109] a Autoimmune C,M Turkey 20 45.6 (14.9) 100% TAS-20 4 
 
Shibata (2014) [111]* Chronic pain C,M Japan 439 61.1 (11) 65% TAS-20 6 
 
Sinikallio (2006) [113] MSK M Finland 100 61.6 (11.2) 58% TAS-20 4 
 
Slavin-Spenny (2003) 
[114] 
Headache M USA 147 22.1 (6) 88% TAS-20 7 
 
Steinweg (2011) [115] a Autoimmune G,M USA 43 59.8 (13.7) 9% TAS-20 7 
 
Steinweg (2011) [115] a Fibromyalgia G,M USA 48 54.1 (13.4) 92% TAS-20 7 
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 Tuzer (2011) [122] a Fibromyalgia G,M Turkey 70 39.0 (7.9) 100% TAS-20 6 
 
Tuzer (2011)  [122] a MSK G,M Turkey 56 44.2 (9.3) 100% TAS-20 6 
 
Vadacca (2014) [123] a* Autoimmune C,M Italy 25 46 (11) 100% TAS-20 5 
 
Vadacca (2014) [123] a* Autoimmune C,M Italy 24 64 (10) 100% TAS-20 5 
 
Valkamo (2001)  [124] Chest pain M Finland 200 58.1 (9.4) 34% TAS-20 4 
 
van Middendorp (2008)  
[125] 
Fibromyalgia C,G,M Netherlands 403 46.5 (12.3) 100% TAS-20 6 
 
Veehof (2011)  [126] Fibromyalgia M Netherlands 141 43.1 (10.9) 92% TAS-20 5 
 Vieira (2013)* [127] Headache C,M Brazil 39 43.6 (10.7) 100% TAS-26 6 
 
Villani (2005)  [128] Headache M Italy 42 35.7 (10.6) 83% TAS-20 3 
 
Villani (2010) [129] Headache M Italy 465 34.7 (10.9) 82% TAS-20 3 
 
White (2011)  [132] Chest pain M USA/Israel 229 50 (10.3) 56% TAS-20 6 
 
Wise (1994)  [133] a Headache M USA 61 37.8 (13.6) NR TAS-26 5 
 
Wise (1994)  [133] a Headache M USA 39 37.8 (13.6) NR TAS-26 5 
 
Yalug (2010) [134] Headache C,M Turkey 300 37.4 (13.8) 83% TAS-20 7 
 
Yucel (2002)  [135] Headache G Turkey 105 33 (10) 78% TAS-26 6 
 
Zeng (2016) [136] Chronic pain C China 147 34.9 (11.3) 100% TAS-20 4 
 
Zincir (2014) [139] Chest pain G,M Turkey 51 33 (7.3) 73% TAS-20 6 
Youth Studies: 
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 Cerutti (2016)  [18] a* Headache C,M Italy 53 13.4 (2.4) 57% TAS-20 4 
 
Gatta (2011)  [33] Headache M,G Italy 32 11.2 (2) 81% AQC 6 
 
Gatta (2015)  [34] a Headache M Italy 42 13.1 (2.4) 57% TAS-20 5 
 
Gatta (2015) [34] a Headache M Italy 47 12.4 (2.3) 77% TAS-20 5 
 
Sayin (2007)  [110] 
Mixed chronic 
pain 
C Turkey 21 14.4 (2.6) 33% TAS-26 3 
Table 1. Summary of studies included in meta-analysis. Note. Study Design column refers to included analyses relevant for the present meta-
analysis: C = correlational, G = group difference, M = mean or prevalence, a represents data from one of two samples reported in the same 
article. MSK = musculoskeletal pain, CPRS = complex regional pain syndrome, TMD = temporomandibular disorder, IBS = irritable bowel 
syndrome, BMS = burning mouth syndrome, NR = not reported. *Additional data provided by author at personal request. 
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    range k n Mean SD 
TAS-20  
    
 
Total Score 20-100 60 5964 52.08 12.97 
 
Difficulty Identifying Feelings 7-35 46 4654 17.79 6.75 
 
Difficulty Describing Feelings  5-25 46 4654 13.73 5.05 
 
Externally Oriented Thinking  8-40 45 4216 20.06 4.83 
TAS-26  
    
 
Total Score  26-156 9 630 66.99   17.66 
Table 2. Pooled alexithymia total and subscale scores for the overall adult sample. Note. Range 
indicates minimum to maximum score. 
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Overall Effect and Heterogeneity 
 
Alexithymia 
Subscale 
Studies 
(k) 
Chronic 
Pain (n) 
Comparison  
(n) 
Effect Size 95% CI I2 
 
       
All Comparisons 
       
 
Total  31 1876 1577 0.77 [0.60, 0.94] 81% 
 
DIF 21 1506 995 0.86 [0.63, 1.10] 85% 
 
DDF 21 1506 995 0.46 [0.32, 0.61] 62% 
 
EOT 18 1068 692 0.18 [-0.07, 0.44] 83% 
Non-Clinical Comparison 
      
 
Total  27 1706 1370 0.81 [0.62, 1.00] 83% 
 
DIF 18 1401 845 0.92 [0.66, 1.19] 86% 
 
DDF 18 1401 845 0.46 [0.29, 0.62] 67% 
 
EOT 16 963 608 0.13 [-0.15, 0.40] 85% 
Medical Comparison 
      
 
Total  4 170 207 0.55 [0.34, 0.77] 0% 
 
DIF 3 140 150 0.51 [0.27, 0.75] 0% 
  DDF 3 140 150 0.57 [0.33, 0.81] 0% 
Table 3. Meta-analysis of differences in alexithymia total and subscale scores between adult samples with chronic pain and comparison 
samples. Note. Insufficient data to meta-analyze differences in EOT in chronic pain versus medical comparison. 
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     Overall Effect and Heterogeneity 
Variable Alexithymia subscale 
Studies 
(k) 
Participants 
(n) 
Effect Size 95% CI I2 
Trim and Fill 
(Y or N) 
Pain intensity 
    
 
 
Total 27 2749 0.20 [13, .28] 70.94 N 
 
Difficulty Identifying Feelings 24 2718 0.18 [.14, .23] 30.94 N 
 
Difficulty Describing Feelings 23 2591 0.19 [.12, .25] 57.47 N 
  Externally Oriented Thinking 22 2188 0.08 [.01, .14] 51.67 N 
Physical Interference   
  
 
 
Total 19 2049 0.17 [.10, .24]  57.22 N 
 
Difficulty Identifying Feelings 18 1880 0.21 [.12, .30]  70.44 N 
 
Difficulty Describing Feelings 17 1752 0.16 [.10, .23] 46.49 N 
 
Externally Oriented Thinking 17 1752 0.03 [-.05, .11] 60.32 N 
Depression 
    
 
 
Total 20 2678 0.46 [.41, .51] 48.27 N 
 
Difficulty Identifying Feelings 21 2260 0.42 [.34, .49] 74.81 N 
 
Difficulty Describing Feelings 20 2132 0.38 [.31, .46] 69.36 N 
 
Externally Oriented Thinking 20 2132 0.20 [.12, .28] 70.43 Y 
Anxiety 
     
 
 
Total 22 2431 0.43 [.36, .49]  62.54 N 
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Table 4. Summary of meta-analyzes of correlations between alexithymia total and subscale scores with variables of interest. 
Note. Small effect size = .2; moderate effect size = .5; large effect size = .8. Significant effects are bolded. I2: 0-29% low 
heterogeneity; 30-49% moderate heterogeneity; 50-74% substantial heterogeneity; 75-100% considerable heterogeneity. 
 
 
Difficulty Identifying Feelings 19 2114 0.46 [.40, .52] 60.71 N 
 
Difficulty Describing Feelings 17 1933 0.38 [.31, .46] 45.10 N 
 
Externally Oriented Thinking 18 1986 0.12 [.04, .20] 68.01 N 
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Table 5. Summary of meta-analyzes of partial correlations between alexithymia total and subscale scores with variables of interest, while controlling for a 
measure of negative affect. Note. Small effect size = .2; moderate effect size = .5; large effect size = .8. I2: 0-29% low heterogeneity; 30-49% moderate 
heterogeneity; 50-74% substantial heterogeneity; 75-100% considerable heterogeneity. 
    
 
Overall Effect and Heterogeneity  
Variable Alexithymia subscale 
Studies 
(k) 
Participants 
(n) 
Effect Size 95% CI I2 
Trim and Fill 
(Y or N) 
Pain Intensity 
    
 
 
Total 14 1621 0.09 [-.04, .21] 83.28 N 
 
Difficulty Identifying Feelings 13 1582 0.06 [-.03, .15] 65.23 N 
 
Difficulty Describing Feelings 11 1323 0.07 [-.40, .36] 82.27 N 
 
Externally Oriented Thinking 12 1522 0.06 [-.04, .16] 71.70 N 
Physical Interference   
  
 
 
Total 10 1101 0.06 [-.06, .16] 63.25 N 
 
Difficulty Identifying Feelings 11 1176 0.03 [-.05, .11] 36.42  
 
Difficulty Describing Feelings 11 1176 0.04 [-.06, .13] 51.36 N 
 
Externally Oriented Thinking 11 1176 -0.01 [-.13, .10] 69.65 N 
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 Records identified through 
database searching 
(n = 1594) 
S
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d
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Additional records identified 
through other sources 
(n =  4) 
Records after duplicates removed 
(n = 1240) 
Records screened 
(n = 1240) 
Records excluded 
(n = 1083) 
Full-text articles 
assessed for eligibility 
(n =  157) 
Full-text articles excluded, with 
primary reason for exclusion 
(n=80): 
 
Poor psychometric properties of 
alexithymia assessment (n = 21) 
Not a chronic pain sample (n= 20) 
Relevant data unavailable (n = 18) 
Primary Psychiatric Diagnosis (n= 
8) 
Recruited high alexithymia 
participants (n=2)  
Administered TAS items selectively 
(n=3) 
Duplicate Sample (n= 5) 
N < 20 (n = 2) 
Record Unavailable (n = 1) 
Manuscripts included in 
qualitative synthesis  
(n = 77) 
Manuscripts included in 
quantitative synthesis 
(meta-analysis) 
(manuscripts = 77) 
(total samples = 87) 
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